Quarterly report · Q3
3034.TEDINET S100SVU6
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥134.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥170.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥126.1bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥5.7bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥6.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥6.5bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.1bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥6.5bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.1bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥115.9bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥101.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥105.5bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥64.2bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥53.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥51.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥47.3bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥23.2bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥101.47 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.64 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.57 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.43 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.8% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥373m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥373m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥2.7bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥123.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥123.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥76m |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥7.6bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥11.6bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥11.3bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥296m |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥884m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥134.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥134.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥373m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥8.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥317m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥317m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥2.6bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥115.4bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥115.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥66m |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥11.1bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.8bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥250m |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥126.4bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥126.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥317m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥9.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 1200200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0308 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 1200200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 1200200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0308 | |
| Cash and deposits | Prior1YearInstant | 18770000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 23164000000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 16951000000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 17046000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 4990000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 6485000000 | JPY |
| Work in process | Prior1YearInstant | 90000000 | JPY |
| Work in process | CurrentQuarterInstant | 139000000 | JPY |
| Supplies | Prior1YearInstant | 205000000 | JPY |
| Supplies | CurrentQuarterInstant | 196000000 | JPY |
| Other ca | Prior1YearInstant | 3208000000 | JPY |
| Other ca | CurrentQuarterInstant | 2898000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -2000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -2000000 | JPY |
| Current assets | Prior1YearInstant | 44214000000 | JPY |
| Current assets | CurrentQuarterInstant | 49927000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 6818000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 7229000000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant | 1538000000 | JPY |
| Tools furniture and fixtures net | CurrentQuarterInstant | 1634000000 | JPY |
| Land | Prior1YearInstant | 6999000000 | JPY |
| Land | CurrentQuarterInstant | 6970000000 | JPY |
| Other net ppe | Prior1YearInstant | 751000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 570000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 16108000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 16405000000 | JPY |
| Goodwill | Prior1YearInstant | 32818000000 | JPY |
| Goodwill | CurrentQuarterInstant | 33055000000 | JPY |
| Software | Prior1YearInstant | 667000000 | JPY |
| Software | CurrentQuarterInstant | 723000000 | JPY |
| Other ia | Prior1YearInstant | 304000000 | JPY |
| Other ia | CurrentQuarterInstant | 214000000 | JPY |
| Intangible assets | Prior1YearInstant | 33790000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 33993000000 | JPY |
| Investment securities | Prior1YearInstant | 142000000 | JPY |
| Investment securities | CurrentQuarterInstant | 134000000 | JPY |
| Stocks of subsidiaries and affiliates | Prior1YearInstant | - | JPY |
| Stocks of subsidiaries and affiliates | CurrentQuarterInstant | 8179000000 | JPY |
| Lease and guarantee deposits | Prior1YearInstant | 3942000000 | JPY |
| Lease and guarantee deposits | CurrentQuarterInstant | 3957000000 | JPY |
| Deferred tax assets | Prior1YearInstant | 2110000000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 1686000000 | JPY |
| Other ioa | Prior1YearInstant | 1616000000 | JPY |
| Other ioa | CurrentQuarterInstant | 1659000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |